Skip to content
Nonprofiteer
← INTERNATIONAL ASSOCIATION FOR THE STUDY OF LUNG CANCER

Form 990 for tax year 2022

Filed by INTERNATIONAL ASSOCIATION FOR THE STUDY OF LUNG CANCER.

Totals

Total revenue
$11,551,380
Total expenses
$14,627,829
Contributions and grants received
$790,597
Grants paid
$0
Program service revenue
$16,694,390
Investment income
-$5,842,161
Other revenue
-$91,446
Total assets, end of year
$25,381,895
Total liabilities, end of year
$10,197,977
Net assets or fund balances, end of year
$15,183,918
Program services expenses (Part IX)
$11,959,889
Management and general expenses
$2,134,310
Fundraising expenses
$533,630
Program service expenses (Part III)
$11,959,889

Program services were 81.8% of total expenses calculated — Part IX's program-services column over total expenses, both as filed.

Line items

Every line the filer filed in Parts VIII, IX and X, as filed and in filed order. Blank columns are left out, and the lines are not forced to add up to the totals above.

Revenue

Part VIII, the statement of revenue.

  • 1b · Membership dues

    $667,983

  • 1f · All other contributions, gifts and grants

    $122,614

  • 2a · Program service revenue: MEETING INCOME

    total $13,462,619 · related or exempt $3,422,706 · excluded $10,039,913

  • 2b · Program service revenue: PUBLICATIONS

    total $1,761,108 · related or exempt $583,405 · excluded $1,177,703

  • 2c · Program service revenue: SCIENTIFIC PROJECTS

    total $1,452,703 · related or exempt $1,133,663 · excluded $319,040

  • 2d · Program service revenue: WEB SEMINARS

    total $17,960 · excluded $17,960

  • 3 · Investment income

    total $210,228 · excluded $210,228

  • 6a · Gross rents

    real property $8,672

  • 6b · Less rental expenses

    real property $0

  • 6c · Rental income or loss

    real property $8,672

  • 6d · Net rental income or loss

    total $8,672 · excluded $8,672

  • 7b · Less cost or other basis and sales expenses

    securities $2,584,048 · other assets $3,468,341

  • 7c · Gain or loss

    securities -$2,584,048 · other assets -$3,468,341

  • 7d · Net gain or loss

    total -$6,052,389 · excluded -$6,052,389

  • 11a · Other revenue: FOREIGN CURRENCY GAIN

    total -$100,118 · excluded -$100,118

  • 11e · Other revenue, total

    -$100,118

Functional expenses

Part IX, the statement of functional expenses.

  • 5 · Compensation of officers, directors and key employees

    total $539,836 · management and general $539,836

  • 7 · Other salaries and wages

    total $2,957,452 · program services $1,725,092 · management and general $848,281 · fundraising $384,079

  • 11b · Fees: legal

    total $24,508 · management and general $24,508

  • 11c · Fees: accounting

    total $49,350 · management and general $49,350

  • 11g · Fees: other

    total $462,981 · program services $220,921 · management and general $218,798 · fundraising $23,262

  • 13 · Office expenses

    total $331,926 · program services $243,746 · management and general $41,874 · fundraising $46,306

  • 16 · Occupancy

    total $205,185 · program services $101,609 · management and general $94,310 · fundraising $9,266

  • 17 · Travel

    total $134,715 · program services $97,222 · management and general $26,621 · fundraising $10,872

  • 19 · Conferences, conventions and meetings

    total $6,719,850 · program services $6,719,850

  • 22 · Depreciation, depletion and amortization

    total $355,905 · program services $285,054 · management and general $50,578 · fundraising $20,273

  • 24a · Other expenses: SCIENTIFIC PROGRAMS

    total $2,110,711 · program services $2,110,711

  • 24b · Other expenses: OTHER PROGRAMS

    total $423,502 · program services $330,812 · management and general $58,159 · fundraising $34,531

  • 24c · Other expenses: BOARD MEETINGS

    total $135,348 · management and general $135,348

  • 24d · Other expenses: COMMUNICATION

    total $56,470 · program services $39,896 · management and general $11,533 · fundraising $5,041

  • 24e · All other expenses

    total $120,090 · program services $84,976 · management and general $35,114

Balance sheet

Part X, book values.

  • 1 · Cash, non-interest-bearing

    beginning of year $6,038,922 · end of year $623,432

  • 2 · Savings and temporary cash investments

    end of year $7,842,263

  • 4 · Accounts receivable

    beginning of year $4,175,676 · end of year $4,783,308

  • 9 · Prepaid expenses and deferred charges

    beginning of year $1,514,332 · end of year $1,875,986

  • 10a · Land, buildings and equipment: cost or other basis

    $1,942,455

  • 10b · Land, buildings and equipment: accumulated depreciation

    $995,283

  • 10c · Land, buildings and equipment, net

    beginning of year $1,562,578 · end of year $947,172

  • 12 · Investments: other securities

    beginning of year $10,007,570 · end of year $8,178,483

  • 15 · Other assets

    beginning of year $0 · end of year $1,131,251

  • 17 · Accounts payable and accrued expenses

    beginning of year $1,937,626 · end of year $1,397,094

  • 19 · Deferred revenue

    beginning of year $4,154,494 · end of year $7,842,263

  • 25 · Other liabilities

    beginning of year $0 · end of year $958,620

  • 27 · Net assets without donor restrictions

    beginning of year $17,206,958 · end of year $15,183,918

Mission and programs · 2022

Mission

TO PROMOTE THE STUDY OF THE ETIOLOGY, EPIDEMIOLOGY, PREVENTION, DIAGNOSIS, TREATMENT AND ALL OTHER ASPECTS OF LUNG CANCER AND OTHER THORACIC MALIGNANCIES.TO PROVIDE EDUCATION AND INFORMATION ABOUT LUNG CANCER AND OTHER THORACIC MALIGNANCIES TO IASLC MEMBERS, TO THE MEDICAL COMMUNITY AT LARGE, AND TO THE PUBLIC.TO USE ALL AVAILABLE MEANS TO ELIMINATE LUNG CANCER AND OTHER THORACIC MALIGNANCIES AS A HEALTH THREAT FOR THE INDIVIDUAL PATIENT AND THROUGHOUT THE WORLD.

  • MEMBERSHIPS AND OTHER PROGRAMS TO ADVANCE THE STUDY OF LUNG CANCER

    Expenses $1,008,602

  • PUBLICATIONS AND SCIENTIFIC PROGRAMS TO PROVIDE EDUCATION TO THE WORLD WIDE LUNG CANCER COMMUNITY REGARDING THE LATEST ADVANCES IN LUNG CANCER TREATMENT.

    Expenses $3,146,193 · Revenue $1,717,068

  • MEETING AND WEB SEMINARS TO DISSEMINATE INFORMATION REGARDING THE LATEST ADVANCES IN LUNG CANCER TREATMENT.

    Expenses $7,805,094 · Revenue $3,422,706

As filed on the 2022 return. The filer continues this part on Schedule O, which is not shown here.

Listed in Part VII

  • Heather Wakelee MD

    PRESIDENT

    Total calculated
    $0
    Hours/week
    10

  • Erik Thunnissen MD

    TREASURER

    Total calculated
    $0
    Hours/week
    10

  • Tetsuya Mitsudomi MD PhD

    PAST PRESIDENT

    Total calculated
    $0
    Hours/week
    10

  • Paul Van Schil MD

    PRESIDENT ELECT

    Total calculated
    $0
    Hours/week
    10

  • Young Tae Kim MD PhD

    DIRECTOR

    Total calculated
    $0
    Hours/week
    3

  • Joachim Aerts MD PhD

    DIRECTOR

    Total calculated
    $0
    Hours/week
    3

  • Roy Herbst MD

    DIRECTOR

    Total calculated
    $0
    Hours/week
    3

  • Andrea Bezjak MD

    SECRETARY

    Total calculated
    $0
    Hours/week
    3

  • Morten Quist PhD

    DIRECTOR

    Total calculated
    $0
    Hours/week
    3

  • Carlos Gil Ferreira MD PhD

    DIRECTOR

    Total calculated
    $0
    Hours/week
    3

  • Jhanelle Gray MD

    DIRECTOR

    Total calculated
    $0
    Hours/week
    3

  • Caicun Zhou PhD

    DIRECTOR

    Total calculated
    $0
    Hours/week
    3

  • Lecia Vandam Sequist MD MPH

    DIRECTOR

    Total calculated
    $0
    Hours/week
    3

  • Ming-Sound Tsao MD Frcpc

    DIRECTOR

    Total calculated
    $0
    Hours/week
    3

  • Paula Ugalde MD

    DIRECTOR

    Total calculated
    $0
    Hours/week
    3

  • Karen L Kelly

    CEO

    Total calculated
    $369,553
    From this org
    $332,435
    From related orgs
    $0
    Other
    $37,118
    Hours/week
    40

    Schedule J breakdown matched by us

    Base
    $332,435
    Bonus
    $0
    Other
    $0
    Deferred
    $28,940
    Nontaxable benefits
    $8,178
    Filer's total
    $369,553

  • John Skadow

    CFO

    Total calculated
    $253,634
    From this org
    $207,401
    From related orgs
    $0
    Other
    $46,233
    Hours/week
    40

    Schedule J breakdown matched by us

    Base
    $199,401
    Bonus
    $8,000
    Other
    $0
    Deferred
    $20,536
    Nontaxable benefits
    $25,697
    Filer's total
    $253,634

  • Murry Wynes

    DIRECTOR OF SCIENTIFIC AFF

    Total calculated
    $231,969
    From this org
    $200,847
    From related orgs
    $0
    Other
    $31,122
    Hours/week
    40

    Schedule J breakdown matched by us

    Base
    $198,347
    Bonus
    $2,500
    Other
    $0
    Deferred
    $19,881
    Nontaxable benefits
    $11,241
    Filer's total
    $231,969

  • Matthew C Yeingst

    CHIEF DEVELOPMENT OFFICER

    Total calculated
    $228,599
    From this org
    $184,040
    From related orgs
    $0
    Other
    $44,559
    Hours/week
    34

    Schedule J breakdown matched by us

    Base
    $182,040
    Bonus
    $2,000
    Other
    $0
    Deferred
    $18,200
    Nontaxable benefits
    $26,359
    Filer's total
    $228,599

  • Rebecca Bunn

    SENIOR ADVISOR SCIENTIFIC

    Total calculated
    $165,518
    From this org
    $136,348
    From related orgs
    $0
    Other
    $29,170
    Hours/week
    40

    Schedule J breakdown matched by us

    Base
    $133,348
    Bonus
    $3,000
    Other
    $0
    Deferred
    $11,446
    Nontaxable benefits
    $17,724
    Filer's total
    $165,518

  • Kathleen M Doherty

    DIRECTOR, HR

    Total calculated
    $158,003
    From this org
    $133,846
    From related orgs
    $0
    Other
    $24,157
    Hours/week
    40

    Schedule J breakdown matched by us

    Base
    $127,346
    Bonus
    $6,500
    Other
    $0
    Deferred
    $13,181
    Nontaxable benefits
    $10,976
    Filer's total
    $158,003

  • Kristin Richeimer

    FORMER INTERIM CEO

    Total calculated
    $211,705
    From this org
    $193,216
    From related orgs
    $0
    Other
    $18,489
    Hours/week
    40

    Schedule J breakdown matched by us

    Base
    $188,216
    Bonus
    $5,000
    Other
    $0
    Deferred
    $14,374
    Nontaxable benefits
    $4,115
    Filer's total
    $211,705

Compensation is as filed in Part VII: reportable pay from this organization and from related organizations, other compensation, and hours per week. The total, marked calculated, is our sum of the three dollar columns, with a blank column counted as $0; the form itself has no total. On a Form 990-EZ the columns are Part IV's instead, and on a Form 990-PF Part VIII's — compensation, contributions to benefit plans, and expense account — and the total sums those. A Schedule J breakdown is as filed: base pay, bonus, other, deferred compensation and nontaxable benefits from this organization, with any from related organizations beside each, and the filer's own total. It is shown with the Part VII listing of the same name on the same return. The form gives no key between the two, so that pairing is ours, and is marked matched by us.

Schedule J

Answered yes

  • 2 · Substantiation required before reimbursing expenses
  • 3 · Independent compensation consultant
  • 3 · Form 990 of other organizations
  • 3 · Approval by the board or compensation committee
  • 4a · Severance or change-of-control payment

Answered no

  • 4b · Supplemental nonqualified retirement plan
  • 4c · Equity-based compensation arrangement
  • 5a · Pay contingent on this organization's revenues
  • 5b · Pay contingent on a related organization's revenues
  • 6a · Pay contingent on this organization's net earnings
  • 6b · Pay contingent on a related organization's net earnings
  • 7 · Other non-fixed payments
  • 8 · Paid under the initial-contract exception

The filer's explanations (Part III)

PART I, LINE 4A
INTERIM CEO - KRISTIN RICHEIMER - $48,217

Part I's answers as filed. A line not listed was left unanswered; on lines 1a and 3 that means the box was not checked.

Grants on this return

No itemized grants to organizations on this return.

Related organizations on this return

Schedule R Part II: tax-exempt organizations related to the filer by control. It does not record shared board members or money.

  • INTERNATIONAL LUNG CANCER FOUNDATION

    501(C)(3) · SUPPORT LUNG CANCER EDUCATION/RESEARCH · CO · controlled entity

    Directly controlled by INTERNATIONAL ASSOCIATION FOR THE STUDY OF LUNG CANCER

Taxable family on this return

Schedule R Parts I, III and IV, as filed. These record ownership and control, not shared board members or money moved.

Disregarded entities

Part I: entities that legally are the filer and file no return of their own.

  • THE EARLY LUNG IMAGING CONFEDERATION (ELIC)

    RESEARCH INITIATIVE FOR LUNG IMAGING · CO · income $43,024 · assets $224,811

    Directly controlled by INTERNATIONAL ASSOCIATION FOR THE STUDY OF LUNG CANCER

  • IASLC FOUNDATION LLC

    SUPPORT LUNG CANCER EDUCATION/RESEARCH · CO · income $0 · assets $0

    Directly controlled by INTERNATIONAL ASSOCIATION FOR THE STUDY OF LUNG CANCER

Provenance

Return type
form_990
Tax year
2022
Filed
2 November 2023
IRS schema version
2022v5.0
Source object
202343069349302739

Check it against the return as filed: the GivingTuesday Data Lake hosts a public copy of the original XML.

The source document this was parsed from is served over the API, which is where bulk and document access live.